Pharmaceutical Contract Sales Organizations Market Key Players and Opportunities by 2030

Pharmaceutical Contract Sales Organizations Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Status : Published
Report Code : TIPRE00030074

Category : Life Sciences
No. of Pages : 221

Available Report Formats :

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Services, Modules, Therapeutic Area, End User, and Geography

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

This text is related
to country scope.

Frequently Asked Questions

What was the estimated pharmaceutical contract sales organizations market size in 2022?

The pharmaceutical contract sales organizations market was valued at US$ 8,212.02 million in 2022.

What are the growth estimates for the pharmaceutical contract sales organizations market till 2030?

The pharmaceutical contract sales organizations market is expected to be valued at US$ 15,820.86 million in 2030.

Who are the major players in the pharmaceutical contract sales organizations market?

The pharmaceutical contract sales organizations market majorly consists of the players, including CMIC Holdings Co. Ltd.; Axxelus; EPS Holdings, Inc.; MaBico, IQVIA, Inc.; Peak PharmA; QFR Solutions; Promoveo Health; Syneous Health Inc.; and Mednext Pharmaceuticals Pvt. Ltd;.

Which segment is dominating the pharmaceutical contract sales organizations market?

The pharmaceutical contract sales organizations market: by service, is segmented into commercial services and non-commercial services. In 2022, the commercial services segment held the largest share of the market and is expected to grow at the fastest rate during the coming years. Commercial services refer to the range of services provided by contract sales organizations (CSOs) to pharmaceutical companies to support their sales and marketing efforts. CSOs are third-party organizations specializing in delivering sales and marketing services on behalf of pharmaceutical companies.

What are the driving factors for the pharmaceutical contract sales organizations market?

Key factors driving the market growth are the increasing integration of digital technologies and the growing interest of pharmaceutical companies to increase sales of products. However, quality issues associated with outsourcing hinder the pharmaceutical contract sales organizations market growth.

What are pharmaceutical contract sales organizations?

Pharmaceutical companies may outsource their sales and marketing functions to third parties, commonly referred to as contract sales organizations, under the pharmaceutical contract sales outsourcing (CSO) business model. Because of the financial benefits, the improved flexibility, and the easy access to specialized knowledge, this practice has gained popularity in the pharmaceutical sector. Companies that manage contract sales teams also offer training, hiring, and performance evaluation. Contract sales outsourcing does, however, come with some drawbacks, including the potential loss of sales process control and the requirement to uphold solid vendor relationships.

1. Introduction

1.1 Scope of the Study

1.2 Market Definition, Assumptions and Limitations

1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness Analysis

3. Research Methodology

4. Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Pharmaceutical Contract Sales Organizations Market - Key Market Dynamics

5.1 Key Market Drivers

5.2 Key Market Restraints

5.3 Key Market Opportunities

5.4 Future Trends

5.5 Impact Analysis of Drivers and Restraints

6. Pharmaceutical Contract Sales Organizations Market - Global Market Analysis

6.1 Pharmaceutical Contract Sales Organizations - Global Market Overview

6.2 Pharmaceutical Contract Sales Organizations - Global Market and Forecast to 2030

7. Pharmaceutical Contract Sales Organizations Market – Revenue Analysis (USD Million) – By Services, 2020-2030

7.1 Overview

7.2 Commercial Services

7.3 Non-Commercial Services

8. Pharmaceutical Contract Sales Organizations Market – Revenue Analysis (USD Million) – By Module, 2020-2030

8.1 Overview

8.2 Syndicated Modules

8.3 Dedicated Modules

9. Pharmaceutical Contract Sales Organizations Market – Revenue Analysis (USD Million) – By Therapeutic Area, 2020-2030

9.1 Overview

9.2 Cardiovascular Disorders

9.3 Oncology

9.4 Metabolic Disorders

9.5 Neurology

9.6 Orthopedic Diseases

9.7 Infectious Diseases

9.8 Others

10. Pharmaceutical Contract Sales Organizations Market – Revenue Analysis (USD Million) – By End User, 2020-2030

10.1 Overview

10.2 Biopharmaceutical Companies

10.3 Pharmaceutical Companies

11. Pharmaceutical Contract Sales Organizations Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis

11.1 North America

11.1.1 North America Pharmaceutical Contract Sales Organizations Market Overview

11.1.2 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts to 2030

11.1.3 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts and Analysis - By Services

11.1.4 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts and Analysis - By Module

11.1.5 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts and Analysis - By Therapeutic Area

11.1.6 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts and Analysis - By End User

11.1.7 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts and Analysis - By Countries

11.1.7.1 United States Pharmaceutical Contract Sales Organizations Market

11.1.7.1.1 United States Pharmaceutical Contract Sales Organizations Market, by Services

11.1.7.1.2 United States Pharmaceutical Contract Sales Organizations Market, by Module

11.1.7.1.3 United States Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area

11.1.7.1.4 United States Pharmaceutical Contract Sales Organizations Market, by End User

11.1.7.2 Canada Pharmaceutical Contract Sales Organizations Market

11.1.7.2.1 Canada Pharmaceutical Contract Sales Organizations Market, by Services

11.1.7.2.2 Canada Pharmaceutical Contract Sales Organizations Market, by Module

11.1.7.2.3 Canada Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area

11.1.7.2.4 Canada Pharmaceutical Contract Sales Organizations Market, by End User

11.1.7.3 Mexico Pharmaceutical Contract Sales Organizations Market

11.1.7.3.1 Mexico Pharmaceutical Contract Sales Organizations Market, by Services

11.1.7.3.2 Mexico Pharmaceutical Contract Sales Organizations Market, by Module

11.1.7.3.3 Mexico Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area

11.1.7.3.4 Mexico Pharmaceutical Contract Sales Organizations Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

11.2 Europe

11.2.1 Germany

11.2.2 France

11.2.3 Italy

11.2.4 Spain

11.2.5 United Kingdom

11.2.6 Rest of Europe

11.3 Asia-Pacific

11.3.1 Australia

11.3.2 China

11.3.3 India

11.3.4 Japan

11.3.5 South Korea

11.3.6 Rest of Asia-Pacific

11.4 Middle East and Africa

11.4.1 South Africa

11.4.2 Saudi Arabia

11.4.3 U.A.E

11.4.4 Rest of Middle East and Africa

11.5 South and Central America

11.5.1 Brazil

11.5.2 Argentina

11.5.3 Rest of South and Central America

12. Industry Landscape

12.1 Mergers and Acquisitions

12.2 Agreements, Collaborations, Joint Ventures

12.3 New Product Launches

12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

13.1 Heat Map Analysis by Key Players

13.2 Company Positioning and Concentration

14. Pharmaceutical Contract Sales Organizations Market - Key Company Profiles

14.1 CMIC Holdings Co., Ltd.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

Note - Similar information would be provided for below list of companies

14.2 Axxelus

14.3 EPS Holdings, Inc.

14.4 MaBico

14.5 IQVIA, Inc.

14.6 Peak Pharma

14.7 QFR Solutions

14.8 Promoveo Health

14.9 Syneous Health Inc.

14.10 Mednext Pharmaceuticals Pvt. Ltd

15. Appendix

15.1 Glossary

15.2 About The Insight Partners

15.3 Market Intelligence Cloud

List of Tables

Table 1. Pharmaceutical Contract Sales Organizations Market Segmentation

Table 4. North America Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 5. North America Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 6. North America Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 7. North America Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 8. North America Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 9. North America Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 10. US Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 11. US Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 12. US Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 13. US Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 14. US Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 15. US Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 16. Canada Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 17. Canada Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 18. Canada Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 19. Canada Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 20. Canada Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 21. Canada Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 22. Mexico Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 23. Mexico Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 24. Mexico Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 25. Mexico Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 26. Mexico Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 27. Mexico Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 28. Europe Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 29. Europe Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 30. Europe Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 31. Europe Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 32. Europe Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 33. Europe Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 34. UK Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 35. UK Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 36. UK Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 37. UK Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 38. UK Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 39. UK Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 40. Germany Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 41. Germany Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 42. Germany Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 43. Germany Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 44. Germany Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 45. Germany Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 46. France Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 47. France Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 48. France Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 49. France Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 50. France Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 51. France Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 52. Italy Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 53. Italy Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 54. Italy Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 55. Italy Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 56. Italy Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 57. Italy Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 58. Spain Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 59. Spain Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 60. Spain Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 61. Spain Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 62. Spain Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 63. Spain Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 64. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 65. Rest of Europe Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 66. Rest of Europe Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 67. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 68. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 69. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 70. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 71. Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 72. Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 73. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 74. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 75. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 76. China Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 77. China Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 78. China Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 79. China Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 80. China Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 81. China Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 82. Japan Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 83. Japan Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 84. Japan Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 85. Japan Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 86. Japan Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 87. Japan Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 88. India Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 89. India Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 90. India Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 91. India Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 92. India Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 93. India Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 94. Australia Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 95. Australia Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 96. Australia Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 97. Australia Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 98. Australia Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 99. Australia Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 100. South Korea Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 101. South Korea Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 102. South Korea Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 | (US$ Million)

Table 103. South Korea Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 104. South Korea Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 105. South Korea Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 106. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 107. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 108. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 109. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 110. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 111. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 112. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 113. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 114. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 115. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 116. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 117. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 118. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 119. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 120. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 121. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 122. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 123. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 124. UAE Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 125. UAE Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 126. UAE Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 127. UAE Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 128. UAE Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 129. UAE Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 130. South Africa Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 131. South Africa Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 132. South Africa Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 133. South Africa Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 134. South Africa Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 135. South Africa Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 136. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 137. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 138. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 139. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 140. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 141. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 142. South & Central America Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 143. South & Central America Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 144. South & Central America Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 145. South & Central America Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 146. South & Central America Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 147. South & Central America Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 148. Brazil Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 149. Brazil Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 150. Brazil Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 151. Brazil Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 152. Brazil Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 153. Brazil Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 154. Argentina Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 155. Argentina Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 156. Argentina Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 157. Argentina Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 158. Argentina Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 159. Argentina Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 160. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by Services – Revenue and Forecast to 2030 (US$ Million)

Table 161. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 162. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services – Revenue and Forecast to 2030 (US$ Million)

Table 163. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by Module – Revenue and Forecast to 2030 (US$ Million)

Table 164. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)

Table 165. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by End User – Revenue and Forecast to 2030 (US$ Million)

Table 166. Recent Organic Growth Strategies in Pharmaceutical Contract Sales Organizations Market

Table 167. Recent Inorganic Growth Strategies in the Pharmaceutical Contract Sales Organizations Market

Table 168. Glossary of Terms, Pharmaceutical Contract Sales Organizations Market

List of Figures

Figure 1. Pharmaceutical Contract Sales Organizations Market Segmentation, By Geography

Figure 2. Global - PEST Analysis

Figure 3. Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 – 2030

Figure 6. Pharmaceutical Contract Sales Organizations Market Revenue, Geography (US$ Mn), 2022 – 2030

Figure 7. Pharmaceutical Contract Sales Organizations Market Revenue Share, by Product Type, 2022 & 2030 (%)

Figure 8. Reagents and Assay Kits: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9. Instruments: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10. Pharmaceutical Contract Sales Organizations Market Revenue Share, by Module 2022 & 2030 (%)

Figure 11. Tandem Mass Spectrometry (TMS): Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12. Molecular Assays: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13. Immunoassays and Enzymatic Assays: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14. Pulse Oximetry Screening Technology: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15. Other Technologies: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16. Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area 2022 & 2030 (%)

Figure 17. Dry Blood Spot Test: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18. Hearing Screen Test: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19. Critical Congenital Heart Diseases (CCHD) Test: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20. Other Test Types: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21. Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 22. Hospitals and Clinics: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23. Diagnostic Laboratories: Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24. North America: Pharmaceutical Contract Sales Organizations Market , by Key Country – Revenue (2022) (US$ Million)

Figure 25. North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. North America Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)

Figure 27. US Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Canada Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 29. Mexico Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 30. Europe Pharmaceutical Contract Sales Organizations Market , by Key Country – Revenue, 2022 (US$ Million)

Figure 31. Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 32. Europe Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)

Figure 33. UK Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 34. Germany Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 35. France Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 36. Italy Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 37. Spain Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 38. Rest of Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 39. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Key Country – Revenue, 2022 (US$ Million)

Figure 40. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 41. Asia Pacific Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)

Figure 42. China Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 43. Japan Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 44. India Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 45. Australia Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 46. South Korea Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 47. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 48. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Key Country – Revenue, 2022 (US$ Million)

Figure 49. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 50. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)

Figure 51. Saudi Arabia Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 52. UAE Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 53. South Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 54. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 55. South & Central America Pharmaceutical Contract Sales Organizations Market , by Key Country – Revenue, 2022 (US$ Million)

Figure 56. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 57. South & Central America Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)

Figure 58. Brazil Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 59. Argentina Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 60. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 61. Growth Strategies in Pharmaceutical Contract Sales Organizations Market

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Please use your business email for quicker response

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.